The European Commission has secured 300 million extra doses of the coronavirus Pfizer-BioNTech vaccine.
Speaking during a news conference in Brussels on Friday, European Commission president Ursula von der Leyen said the agreement will double the number of doses ordered by the 27-nation bloc. The EU commission later said in a statement that the Commission has proposed to member states to purchase an additional 200 million doses of the vaccine, with the option to acquire another 100 million doses.
“This would enable the EU to purchase up to 600 million doses of this vaccine, which is already being used across the EU. The additional doses will be delivered starting in the second quarter of 2021,” the EU said.
Combined with the contract finalized with Moderna — the second vaccine authorized so far in the region — Von der Leyen said the EU has now the capacity to vaccinate 380 million people, more than 80 percent of the EU population.